08 February 2021
The Impact of Biologics on the Future of Small Molecules.
I've collaborated with multiple leading experts at major small molecule CDMOs to talk about the impact that biologics has has on their industry.
This article featured in the January/February 2021 edition of Speciality Chemicals Magazine. If you'd like to give it a read, got to pages 26 and 27 of the magazine.
Click here to go to the magazine.
If you'd like to talk to me about the article, discuss your hiring plans or chat about advancing your own careers within the CDMO space; please email me at Jack.Shute@lifesci-cm.com.
Recommended.
26 May 2022
Pure or Integrated? That is the Question.
Developing and manufacturing drugs is more expensive and complicated than ever before. Many outsource to CDMO's, but which approach truly offers the most value? Click to read more.
09 December 2021
Is This the Most Exciting Time Ever for CDMOs?
As small-molecule CDMOs pivot their businesses to meet the demands of the life science sector, I spoke with CEO & Founder Tia Lyles-Williams to find out what this really means for the industry. Click to find out more.
16 August 2021
How are we Addressing the Lack of Diversity in Clinical Trials?
What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.
.jpg)
08 July 2021
"Always be Visible and Always be Available"
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
Comments.